Table 2. Characteristics of the patients in the implementation sample (n=170).
| Attributes of the patients | Numbers and rates |
|---|---|
| Age (years, x˜ (range)) (n=170) | 58 (34–86) |
| Time after primary treatment (months, x˜ (i.q. range and range)) (n=168) | 4 (1–31) and (1–202) |
| Prognostic stage grouping (UICC, n=153) | |
| UICC 0 | 4 |
| UICC I | 65 |
| UICC II (II a and b combined) | 64 |
| UICC III (III a, b, c combined) | 9 |
| UICC IV | 11 |
| Receptor status | |
| Estrogen positive/negative | 137/23 |
| Progesterone positive/negative | 126/34 |
| Her2neu positive/negative | 35/82 |
| Present phase of therapy | |
| Postoperative, BCT/mastectomy | 100/63 |
| Chemotherapy positive/negative | 20/148 |
| Radiotherapy positive/negative | 7/161 |
| Endocrine therapy positive/negative | 61/107 |
| Professional status | |
| Housewife | 46 |
| Working outside the home | 100 |
| On pension | 24 |
| Family status | |
| Married/not married | 122/40 |
| Children/no children | 137/28 |
Numbers less than 170 in the sample are due to missing values.